Non-DM (N = 487) | DM (N = 126) | Total (N = 613) | P-value | OR | 95% C.I. | P-value | ||||
---|---|---|---|---|---|---|---|---|---|---|
N | % | N | % | N | % | |||||
Gender | 0.449 | |||||||||
Male | 454 | 93.2% | 115 | 91.3% | 569 | 92.8% | ||||
Female | 33 | 6.8% | 11 | 8.7% | 44 | 7.2% | ||||
Tobacco smoking | 0.4 | |||||||||
Daily | 290 | 59.5% | 70 | 55.6% | 360 | 58.7% | ||||
Non-smoker | 197 | 40.5% | 56 | 44.4% | 253 | 41.3% | ||||
Alcohol abuse | 0.6 | |||||||||
Daily | 51 | 10.5% | 15 | 11.9% | 66 | 10.8% | ||||
None or social | 436 | 89.5% | 111 | 88.1% | 547 | 89.2% | ||||
Age (yr) | 52.46 ± 11.30 | 56.42 ± 9.46 | 53.28 ± 11.06 | p < 0.001 | 1.04 | 1.02–1.06 | ||||
Survival status | p < 0.001 | |||||||||
Dead | 128 | 26.3% | 70 | 55.6% | 198 | 32.3% | 2.59 | 1.65–4.05 | p < 0.001 | |
Survival | 359 | 73.7% | 56 | 44.4% | 415 | 67.7% | 1.00 | |||
N status | p < 0.001 | |||||||||
N = 0 | 317 | 65.4% | 55 | 43.7% | 372 | 60.9% | 1.00 | |||
N > 0 | 168 | 34.6% | 71 | 56.3% | 239 | 39.1% | 1.68 | 1.01–2.79 | 0.044 | |
Tumor size | 0.081 | |||||||||
T1 – T3 | 215 | 44.3% | 45 | 35.7% | 260 | 42.6% | ||||
T4 | 270 | 55.7% | 81 | 64.3% | 351 | 57.4% | ||||
Tumor stage | p < 0.001 | |||||||||
I–II | 126 | 26.0% | 14 | 11.1% | 140 | 22.9% | 1.00 | |||
III–IV | 359 | 74.0% | 112 | 88.9% | 471 | 77.1% | 1.55 | 0.8–3.03 | 0.196 | |
Lymphovascular permeation | 0.031 | |||||||||
Positive | 81 | 16.9% | 31 | 25.4% | 112 | 18.6% | 0.89 | 0.51–1.54 | 0.669 | |
Negative | 398 | 83.1% | 91 | 74.6% | 489 | 81.4% | 1.00 | |||
Cell differentation | 0.572 | |||||||||
Well | 178 | 36.6% | 42 | 33.3% | 220 | 35.9% | ||||
Moderate | 278 | 57.1% | 73 | 57.9% | 351 | 57.3% | ||||
Poor | 31 | 6.4% | 11 | 8.7% | 42 | 6.9% | ||||
Perineural invasion | 0.306 | |||||||||
Negative | 381 | 78.9% | 91 | 74.6% | 472 | 78.0% | ||||
Positive | 102 | 21.1% | 31 | 25.4% | 133 | 22.0% |